|
Nancy Dreyer is Chief of Scientific Affairs for Outcome. Dr. Dreyer has more than 20 years of experience in the design, conduct and interpretation of pharmacoepidemiologic research. At Outcome, she leads a team of epidemiologists, biostatisticians and clinical program designers who work together on observational research and quality improvement programs. She is the Project Director for Outcome's DEcIDE Center for the Agency for Healthcare Research and Quality (AHRQ). Under this program, Outcome and Dr. Dreyer, as a senior editor and author, led the creation of the AHRQ handbook, "Registries for Evaluating Patient Outcomes: A User's Guide," a reference for the creation, execution and evaluation of registries.
Dr. Dreyer trained at the University of North Carolina in Chapel Hill, earning a masters degree and doctorate in epidemiology, and was named a Fellow of the International Society of Pharmacoepidemiology in 2003. Her credentials include working as CEO of Epidemiology Resources Inc. from its inception through its acquisition 20 years later by UnitedHealth; directing an internationally renowned postgraduate summer epidemiology program in collaboration with Tufts Medical School and Boston University School of Public Health; and launching the peer-reviewed journal, Epidemiology. At UnitedHealth Group, Dr. Dreyer spent 5 years in various senior management positions in the epidemiology, outcomes and the CRO divisions of Ingenix, a wholly owned subsidiary of UnitedHealth. She has more than 60 publications, and has mentored many more.
In addition to her work at Outcome, Dr. Dreyer has been a director of the Drug Research Group since 1993. She is a member of the Brandeis University Board of Overseers for the Heller School for Social Policy and Management, and the University of North Carolina School of Public Health Dean's Advisory Council. She served as a Consumer Representative to the FDA for 4 years in radiopharmaceuticals, and has served on advisory committees for industry and trade associations. | 